PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 42 filers reported holding PLX PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 245 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -99.1% | 245 | -99.1% | 0.00% | – |
| Q1 2022 | $116,000 | -37.3% | 28,702 | +24.2% | 0.00% | – |
| Q4 2021 | $185,000 | -31.7% | 23,107 | +64.4% | 0.00% | – |
| Q3 2021 | $271,000 | +135.7% | 14,057 | +69.3% | 0.00% | – |
| Q2 2021 | $115,000 | – | 8,305 | +16510.0% | 0.00% | – |
| Q1 2021 | $0 | – | 50 | +4900.0% | 0.00% | – |
| Q3 2020 | $0 | – | 1 | -98.6% | 0.00% | – |
| Q2 2020 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 73 | +265.0% | 0.00% | – |
| Q4 2019 | $0 | – | 20 | -63.0% | 0.00% | – |
| Q3 2019 | $0 | – | 54 | +5300.0% | 0.00% | – |
| Q2 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 1,875,000 | $4,556,000 | 0.28% |
| Ground Swell Capital, LLC | 48,931 | $119,000 | 0.22% |
| Park West Asset Management LLC | 1,473,218 | $3,580,000 | 0.20% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $152,000 | 0.07% |
| Eidelman Virant Capital | 27,000 | $63,000 | 0.04% |
| MBL Wealth, LLC | 52,000 | $126 | 0.03% |
| O'Brien Greene & Co. Inc | 22,340 | $54,000 | 0.02% |
| SHUFRO ROSE & CO LLC | 56,800 | $138,000 | 0.01% |
| GW&K Investment Management, LLC | 424,921 | $1,033,000 | 0.01% |
| EXANE DERIVATIVES | 6,575 | $15,974,000 | 0.01% |